Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5284006
Max Phase: Preclinical
Molecular Formula: C43H39ClN8O7S
Molecular Weight: 847.35
Associated Items:
ID: ALA5284006
Max Phase: Preclinical
Molecular Formula: C43H39ClN8O7S
Molecular Weight: 847.35
Associated Items:
Canonical SMILES: Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)NCCCNC(=O)c1ccc(COc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)cc1)c1nnc(C)n1-2
Standard InChI: InChI=1S/C43H39ClN8O7S/c1-22-23(2)60-43-35(22)37(26-12-14-28(44)15-13-26)47-30(38-50-49-24(3)51(38)43)20-34(54)45-18-5-19-46-39(55)27-10-8-25(9-11-27)21-59-32-7-4-6-29-36(32)42(58)52(41(29)57)31-16-17-33(53)48-40(31)56/h4,6-15,30-31H,5,16-21H2,1-3H3,(H,45,54)(H,46,55)(H,48,53,56)/t30-,31?/m0/s1
Standard InChI Key: YAGRQNPAJXKXTD-FSRLHOSWSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 847.35 | Molecular Weight (Monoisotopic): 846.2351 | AlogP: 5.11 | #Rotatable Bonds: 12 |
Polar Surface Area: 194.05 | Molecular Species: NEUTRAL | HBA: 12 | HBD: 3 |
#RO5 Violations: 3 | HBA (Lipinski): 15 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.59 | CX Basic pKa: 4.30 | CX LogP: 4.02 | CX LogD: 4.02 |
Aromatic Rings: 5 | Heavy Atoms: 60 | QED Weighted: 0.11 | Np Likeness Score: -0.89 |
1. Ding M, Shao Y, Sun D, Meng S, Zang Y, Zhou Y, Li J, Lu W, Zhu S.. (2023) Design, synthesis, and biological evaluation of BRD4 degraders., 78 [PMID:36563515] [10.1016/j.bmc.2022.117134] |
Source(1):